Bryan Dechairo - 04 Feb 2026 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Operating Officer
Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
04 Feb 2026
Net transactions value
-$510,874
Form type
4
Filing time
06 Feb 2026, 16:19:01 UTC
Previous filing
03 Feb 2026
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dechairo Bryan Chief Operating Officer C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD /s/ Bridget Brown, Attorney-in-Fact 06 Feb 2026 0002051759

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Sale $64,684 -779 -13% $83.04 5,182 04 Feb 2026 Direct F1, F2
transaction WGS Class A Common Stock Sale $119,456 -1,425 -27% $83.83 3,757 04 Feb 2026 Direct F1, F3
transaction WGS Class A Common Stock Sale $87,816 -1,034 -28% $84.93 2,723 04 Feb 2026 Direct F1, F4
transaction WGS Class A Common Stock Sale $53,796 -623 -23% $86.35 2,100 04 Feb 2026 Direct F1, F5
transaction WGS Class A Common Stock Sale $137,804 -1,572 -75% $87.66 528 04 Feb 2026 Direct F1, F6
transaction WGS Class A Common Stock Sale $29,082 -328 -62% $88.66 200 04 Feb 2026 Direct F1, F7
transaction WGS Class A Common Stock Sale $9,045 -100 -50% $90.45 100 04 Feb 2026 Direct F1, F8
transaction WGS Class A Common Stock Sale $9,192 -100 -100% $91.92 0 04 Feb 2026 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.33 to $83.31 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 8 of this Form 4.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.33 to $84.32 per share, inclusive.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.50 to $85.41 per share, inclusive.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.77 to $86.70 per share, inclusive.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.30 to $88.26 per share, inclusive.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.34 to $88.80 per share, inclusive.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.44 to $90.51 per share, inclusive.
F9 Following the reported transactions, which were undertaken pursuant to the reporting person's 10b5-1 trading plan, the reporting person beneficially owned RSUs representing contingent rights to receive up to an aggregate 28,123 shares of Class A Common Stock, which RSUs vest according to their terms.